TGF-β antagonists: Why suppress a tumor suppressor?
- 15 June 2002
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 109 (12), 1533-1536
- https://doi.org/10.1172/jci15970
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Transforming Growth Factor-β Stimulates Parathyroid Hormone-related Protein and Osteolytic Metastases via Smad and Mitogen-activated Protein Kinase Signaling PathwaysJournal of Biological Chemistry, 2002
- Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effectsJournal of Clinical Investigation, 2002
- Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effectsJournal of Clinical Investigation, 2002
- Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastasesJournal of Clinical Investigation, 2002
- TGF-β signaling: positive and negative effects on tumorigenesisCurrent Opinion in Genetics & Development, 2002
- Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasisThe Journal of cell biology, 2002
- TGF- β signaling in cancer – a double-edged swordTrends in Cell Biology, 2001
- Induction of Angiogenesis by Expression of Soluble Type II Transforming Growth Factor-β Receptor in Mouse HepatomaPublished by Elsevier ,2001
- Decorin gene transfer-mediated suppression of TGF-β synthesis abrogates experimental malignant glioma growth in vivoGene Therapy, 1998
- Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiencyNature Medicine, 1998